- NovaLash® produces products that:
- Are Medical Grade
- Are Physician Formulated.
- Do not contain any detectable formaldehyde as manufactured and delivered in the bottle and as confirmed by testing under EPA method TO-11A/8315HPLC-UV.*
- Contain only ingredients approved by the FDA for medical and/or cosmetic use. **
- Are AE-WCA Approved. ***
- Are ISO-10993 Certified. ****
- Have a Patent Pending Adhesive Formula. (Patent Application No: 20080196732)
- Have a Patent Pending Quality Control System for Eyelash Extensions. (Patent Application No: PCT/1B2006/001293)
*NovaLash’s adhesives are in full compliance with the FDA’s recommended maximum concentration for formaldehyde of 0.2% for cosmetics. When using EPA method TO-11A/8315HPLC-UV, NovaLash’s adhesives do not contain any detectable formaldehyde as manufactured and delivered in the bottle. Laboratory tests show that there is no detectable formaldehyde present in the bottle in NovaLash’s adhesives based upon a detection limit of 0.05 parts per billion or 1 nanogram per cubic meter.
** NovaLash goes to great lengths to eliminate the formation of formaldehyde in its adhesive during the manufacturing process. There are many extra steps followed to purify our adhesives. If these steps are not followed, formaldehyde can form in the bottle as a bi-product of exposure to water vapor in the air.
*** The American Extended-Wear Cosmetics Association (AE-WCA) is a board of medical professionals that reviews the safety and quality/performance of products such as cosmetic tattoo pigments, lash extension adhesives and removers, and sunless tanning products. Cosmetic products like these, which are worn on the skin or hair for extended periods of time, are tested for the presence of ingredients that can be harmful to the health of both consumers and the professionals who work with them. Sophy Merszei, NovaLash company president, is proud to be the founding member of this organization and currently sits on the board of the AE-WCA. At present, the AE-WCA has a sister organization in Japan, Espoir, comprised of a beauty school and two lash salons, also instrumental in founding an organization dedicated to health and safety standards for the eyelash extension industry in Japan.
**** The ISO 10993 set entails a series of standards for evaluating the biocompatibility of a medical device prior to a clinical study. These documents were preceded by the Tripartite agreement and is a part of the harmonisation of the safe use evaluation of medical devices. www.iso.org